Cineworld: what’s going on with this penny stock?

The Cineworld share price has crashed by more than 40% in the past year, turning it into a penny stock. Can it recover?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British Pennies on a Pound Note

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Cinema chain Cineworld (LSE: CINE) has seen a curious share price trend recently. Over the past year, its share price is up 13.4%. This is hardly among the biggest increases, but it is still somewhat respectable. I cannot say the same about its share price change over the past six months, however. It has fallen by a significant 41%, crashing into penny stock territory. As I write, it is trading at around 66p.

What is going on here?

Coronavirus haunts the Cineworld stock

To sum up in two words, continued uncertainty. The FTSE 250 cinema chain has been among stocks worst hit by the pandemic. Even though it appears that the worst of Covid-19 is now behind us, there is no guarantee that clear progress will follow. The Centre for Disease Control and Prevention (CDC) predicts that in the month, coronavirus deaths in the US will rise to levels last seen in March this year, when the vaccines were still taking effect.

The US is the largest market for movies, if we ignore the atypical trends for last year, so uncertainty there could be particularly damaging for cinemas. This is already becoming evident. Release dates for potential money spinners like the Tom Cruise starring Top Gun sequel and Mission Impossible 7, have been pushed to next year because of the pandemic risk. 

I reckon that the relatively limited progress in handling the pandemic and its impact on movie releases is keeping investors at arm’s length from highly sensitive stocks like Cineworld. So even though much euphoria surrounded them when vaccines first came into the picture, it died down in the following few months. As a result, much of the share price progress seen during last November’s share price rally has been wiped out over the past half year. 

Why I’m still optimistic

Still, I think there is room for optimism here. Initial signs of a pick up in audience numbers are evident. Spending per viewer has also risen a fair bit. And there is still a spate of potential blockbusters ready for release including a James Bond, yet another Spider Man and even the fourth in the Matrix series.

Based on these factors, I am optimistic about the Cineworld stock. Even if it takes a while before swinging back into profits, its revenues should start growing. This can also give it a better chance to start paying off its huge debts. 

My takeaway

And that in itself can be a positive for its share price. In fact, I think the chance of this happening is far higher than a big potential setback from coronavirus in the coming months. The risk exists, to be sure, but so do solutions. 

I think that at its present dirt-cheap levels, Cineworld is a penny stock I shouldn’t miss. And that is why I have bought it already.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh owns shares of Cineworld Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »